BPharm 2002, MHlthMgt 2013, GradDipClinPharm 2018, PhD Candidate.


Marissa has two decades' worth of experience as a cancer pharmacist in both Australia and the United Kingdom. Marissa is currently completing her PhD on the development, implementation and evaluation of a cancer pharmacy telehealth service. Her other published collaborative work includes the Clinical Oncology Society of Australia (COSA) Position Statement 2022 update on the safe handling of monoclonal antibodies in healthcare settings, medication safety related articles, and shared-care models. She is Co-chair of the COSA Cancer Pharmacists Group and a member of the Executive Committee of the COSA Global Oncology Group and works in the Pharmacy Department at Princess Alexandra Hospital, Brisbane, as Team Leader Pharmacist and Acting Consultant Pharmacist in the Cancer Pharmacy team.